RINVOQ 30 mg prolonged-release tablets*

Company

AbbVie Limited

Active Ingredient

• Upadacitinib

Dosage Form

Prolonged-release tablet

Legal Category

A - prescription, may not be renewed

*Additional information is available within the SPC or upon request to the company